DrugCite
Search

MERISLON

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Merislon Adverse Events Reported to the FDA Over Time

How are Merislon adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Merislon, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Merislon is flagged as the suspect drug causing the adverse event.

Most Common Merislon Adverse Events Reported to the FDA

What are the most common Merislon adverse events reported to the FDA?

Alanine Aminotransferase Increased
12 (5.74%)
Aspartate Aminotransferase Increase...
12 (5.74%)
Liver Disorder
9 (4.31%)
Blood Bilirubin Increased
7 (3.35%)
Drug Eruption
7 (3.35%)
Blood Alkaline Phosphatase Increase...
6 (2.87%)
Blood Creatine Phosphokinase Increa...
6 (2.87%)
Blood Creatinine Increased
6 (2.87%)
Blood Pressure Decreased
6 (2.87%)
Blood Urea Increased
6 (2.87%)
C-reactive Protein Increased
6 (2.87%)
Show More Show More
Dehydration
6 (2.87%)
Erythema
6 (2.87%)
Fibrin Degradation Products Increas...
6 (2.87%)
General Physical Health Deteriorati...
6 (2.87%)
Infection
6 (2.87%)
Multi-organ Failure
6 (2.87%)
Oral Mucosa Erosion
6 (2.87%)
Respiratory Disorder
6 (2.87%)
Skin Erosion
6 (2.87%)
Toxic Epidermal Necrolysis
6 (2.87%)
Gamma-glutamyltransferase Increased
5 (2.39%)
Platelet Count Decreased
4 (1.91%)
Dermatitis Exfoliative
3 (1.44%)
Disseminated Intravascular Coagulat...
3 (1.44%)
Dizziness
3 (1.44%)
Pyrexia
3 (1.44%)
Sepsis
3 (1.44%)
Alpha Tumour Necrosis Factor Increa...
2 (.96%)
Blood Lactate Dehydrogenase Increas...
2 (.96%)
Blood Potassium Decreased
2 (.96%)
Cardiac Arrest
2 (.96%)
Contusion
2 (.96%)
Depressed Level Of Consciousness
2 (.96%)
Drug Interaction
2 (.96%)
Hepatic Function Abnormal
2 (.96%)
Interleukin Level Increased
2 (.96%)
Interstitial Lung Disease
2 (.96%)
Laboratory Test Abnormal
2 (.96%)
Memory Impairment
2 (.96%)
Sudden Hearing Loss
2 (.96%)
Thrombocytopenic Purpura
2 (.96%)
Tinnitus
2 (.96%)
Transient Ischaemic Attack
2 (.96%)
Urinary Incontinence
2 (.96%)
Altered State Of Consciousness
1 (.48%)
Body Temperature Increased
1 (.48%)
Cerebellar Ataxia
1 (.48%)
Endotracheal Intubation
1 (.48%)
Gait Disturbance
1 (.48%)
Jaundice
1 (.48%)
Lymphocyte Stimulation Test Positiv...
1 (.48%)
Malaise
1 (.48%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Merislon, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Merislon is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Merislon

What are the most common Merislon adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Merislon, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Merislon is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Merislon According to Those Reporting Adverse Events

Why are people taking Merislon, according to those reporting adverse events to the FDA?

Dizziness
134
Drug Use For Unknown Indication
17
Vertigo
11
Menieres Disease
9
Product Used For Unknown Indication
7
Cerebral Infarction
5
Show More Show More
Ill-defined Disorder
4
Otitis Media
4
Insomnia
3
Sudden Hearing Loss
2
Autonomic Nervous System Imbalance
2
Prophylaxis
1
Psychosomatic Disease
1
Nausea
1
Dystonia
1
Dizziness Postural
1

Merislon Case Reports

What Merislon safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Merislon. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Merislon.